Please login to the form below

Not currently logged in
Email:
Password:

Cadence Pharma

This page shows the latest Cadence Pharma news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma

As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... bought Cadence Pharma for $1.3bn, Questcor for $6.5bn, immunotherapy outfit Therakos for $1.3bn and nuclear

Latest news

  • Ireland's Mallinckrodt buys US regenerative medicine firm Ireland's Mallinckrodt buys US regenerative medicine firm

    Stratatech’s StrataGraft in phase III testing for burns treatment. Ireland's Mallinckrodt Pharma has continued its acquisitive streak with a deal to buy Stratatech, a US firm developing a biologic ... Cadence Pharma and its injectable painkiller

  • Mallinckrodt cuts $5.6bn deal to buy Questcor Mallinckrodt cuts $5.6bn deal to buy Questcor

    Irish company continues move from medical imaging to pharma products. Mallinckrodt has dug deep into its pockets to buy Questcor Pharma and gain ownership of its fast-growing specialty drug HP ... It is the second transaction for Mallinckrodt in as many

  • Mallinckrodt offers $1.3bn for Cadence Pharma

    Deal would include injectable painkiller Ofirmev. Irish pharma company Mallinckrodt has agreed a $1.3bn deal to buy US biotech Cadence Pharmaceuticals and its fast-growing injectable painkiller Ofirmev. ... Mallinckrodt's offer comes shortly after

  • Cadence IV pain drug approved

    Cadence Pharmaceuticals has won US FDA approval for Ofirmev,  the first intravenous formulation of acetaminophen to be marketed in the US. ... Cadence Pharmaceuticals has won US Food and Drug Administration (FDA) approval for Ofirmev, which will become

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...

Infographics